ePosters
While total knee arthroplasty (TKA) is an effective surgical procedure, persistent postoperative pain can still impact up to 20% of patients. Percutaneous 60-Day Peripheral Nerve Stimulation (PNS) has been proven to reduce pain and improve function in patients with both persistent (chronic) and acute postoperative pain1-4. The present analysis evaluated the efficacy of Percutaneous 60-Day PNS in relieving persistent postoperative pain and improving function following TKA up to 12 months after PNS treatment.
Yashar Eshraghi, MD
Department of Anesthesiology
Ochsner Medical Center, United States
Stuart Grant, MD
Department of Anesthesiology
University of North Carolina School of Medicine, United States
Johnathan Goree, MD
Department of Anesthesiology
University of Arkansas for Medical Sciences, United States
David Dickerson, MD
Department of Anesthesiology, Critical Care, and Pain Medicine
Endeavor Health, United States
Sandeep Vaid, MD
Pain Medicine
Better Health Clinical Research, United States
Ali Valimahomed, MD
Pain Medicine
Grammercy Pain Medicine, United States
Jarna Shah, MD
Department of Anesthesiology
University of Arkansas for Medical Sciences, United States
G Lawson Smith, MD
Associate Professor of Anesthesiology
University of Arkansas for Medical Sciences, United States
John Finneran, MD
Department of Anesthesiology
University of California San Diego, United States
Nirav Shah, MD
Pain Medicine
Endeavor Health, United States
Maged Guirguis, MD
Pain Management Physician
Ochsner Health System, United States
Maxim Eckmann, MD (he/him/his)
Professor & Chair, Department of Anesthesiology
UT Health San Antonio
San Antonio, United States
Ajay Antony, MD
Pain Medicine
The Orthopaedic Institute, United States
Brian Ohlendorf, MD
Department of Anesthesiology
Duke University, United States
Mayank Gupta, MD
Pain Medicine
Neuroscience Research Center, United States
John Gilbert, PhD
Senior Research Engineer
SPR, United States
Amorn Wongsarnpigoon, PhD
Research & Development, Director
SPR, United States
Joseph W. Boggs, PhD
Chief Scientific Officer & Senior Vice President, Research and Development
SPR
Cleveland, Ohio, United States